Követés
Iakovos Toumazis
Iakovos Toumazis
Assistant Professor, Department of Health Services Research, MD Anderson Cancer Center
E-mail megerősítve itt: mdanderson.org - Kezdőlap
Cím
Hivatkozott rá
Hivatkozott rá
Év
Evaluation of the benefits and harms of lung cancer screening with low-dose computed tomography: modeling study for the US Preventive Services Task Force
R Meza, J Jeon, I Toumazis, K Ten Haaf, P Cao, M Bastani, SS Han, ...
Jama 325 (10), 988-997, 2021
3082021
Risk-Based lung cancer screening: A systematic review
I Toumazis, M Bastani, SS Han, SK Plevritis
Lung cancer 147, 154-186, 2020
2402020
Routing hazardous materials on time-dependent networks using conditional value-at-risk
I Toumazis, C Kwon
Transportation Research Part C: Emerging Technologies 37, 73-92, 2013
1252013
Cost-effectiveness analysis of lung cancer screening in the United States: a comparative modeling study
SD Criss, P Cao, M Bastani, K Ten Haaf, Y Chen, DF Sheehan, EF Blom, ...
Annals of internal medicine 171 (11), 796-804, 2019
1242019
A comparative modeling analysis of risk-based lung cancer screening strategies
K Ten Haaf, M Bastani, P Cao, J Jeon, I Toumazis, SS Han, SK Plevritis, ...
JNCI: Journal of the National Cancer Institute 112 (5), 466-479, 2020
1082020
Development and validation of a multivariable lung cancer risk prediction model that includes low-dose computed tomography screening results: a secondary analysis of data from …
MC Tammemägi, K Ten Haaf, I Toumazis, CY Kong, SS Han, J Jeon, ...
JAMA network open 2 (3), e190204-e190204, 2019
992019
Disparities of national lung cancer screening guidelines in the US population
SS Han, E Chow, K Ten Haaf, I Toumazis, P Cao, M Bastani, ...
JNCI: Journal of the National Cancer Institute 112 (11), 1136-1142, 2020
652020
Worst-case conditional value-at-risk minimization for hazardous materials transportation
I Toumazis, C Kwon
Transportation Science 50 (4), 1174-1187, 2016
622016
Value-at-risk and conditional value-at-risk minimization for hazardous materials routing
I Toumazis, C Kwon, R Batta
Handbook of OR/MS Models in Hazardous Materials Transportation. 193, 127-154, 2013
522013
Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening
I Toumazis, K de Nijs, P Cao, M Bastani, V Munshi, K Ten Haaf, J Jeon, ...
JAMA oncology, 2021
512021
Evaluating the impact of varied compliance to lung cancer screening recommendations using a microsimulation model
SS Han, SA Erdogan, I Toumazis, A Leung, SK Plevritis
Cancer Causes & Control 28, 947-958, 2017
472017
Handbook of OR/MS models in hazardous materials transportation
R Batta, C Kwon
Springer, 2013
362013
Cost-effectiveness analysis of lung cancer screening accounting for the effect of indeterminate findings
I Toumazis, EB Tsai, SA Erdogan, SS Han, W Wan, A Leung, SK Plevritis
JNCI cancer spectrum 3 (3), pkz035, 2019
332019
Risk model–based lung cancer screening: a cost-effectiveness analysis
I Toumazis, P Cao, K de Nijs, M Bastani, V Munshi, M Hemmati, ...
Annals of internal medicine 176 (3), 320-332, 2023
302023
Prevalence of lung cancer screening among eligible adults in 4 US states in 2021
KG Maki, NQP Tan, I Toumazis, RJ Volk
JAMA Network Open 6 (6), e2319172-e2319172, 2023
262023
A risk‐based framework for assessing real‐time lung cancer screening eligibility that incorporates life expectancy and past screening findings
I Toumazis, O Alagoz, A Leung, SK Plevritis
Cancer 127 (23), 4432-4446, 2021
172021
Evaluation of the Benefits and Harms of Lung Cancer Screening with Low-Dose Computed Tomography: A Collaborative Modeling Study for the US Preventive Services Task Force. AHRQ …
R Meza, J Jeon, I Toumazis, K Ten Haaf, P Cao, M Bastani
Agency for Healthcare Research and Quality, 2020
152020
A cost-effectiveness analysis of lung cancer screening with low-dose computed tomography and a diagnostic biomarker
I Toumazis, SA Erdogan, M Bastani, A Leung, SK Plevritis
JNCI cancer spectrum 5 (6), pkab081, 2021
142021
Synthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of concept
M Salehjahromi, TV Karpinets, SJ Sujit, M Qayati, P Chen, M Aminu, ...
Cell Reports Medicine 5 (3), 2024
82024
Impact of US Preventive Services Task Force lung cancer screening update on drivers of disparities in screening eligibility
KG Maki, R Talluri, I Toumazis, S Shete, RJ Volk
Cancer medicine 12 (4), 4647-4654, 2023
72023
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20